AAV9 Capsid Variants with Improved CNS Transduction Identified by Directed Evolution

被引：0
|
作者：
Rohovie, Marcus [1 ]
Kruse, Nikki [1 ]
Schmitt, Christopher [1 ]
Wong, Victoria [1 ]
Sero, Antoinette [1 ]
Rivera-Velazquez, Mirella [1 ]
Lee, Grace [1 ]
Desautel, Sarah [1 ]
Del Greco, Elizabeth [1 ]
Sedighi, Faezeh [1 ]
Nivina, Aleksandra [1 ]
Jenne, Stephan [1 ]
Gebretsadik, Kahsay [1 ]
Kumar, Ambuj [1 ]
Chng, Chinping [1 ]
Akeefe, Hassibullah [1 ]
Silverman, Adam [1 ]
机构：
[1] Codexis Inc, San Carlos, CA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1400
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [1] Engineered AAV9 Variants for Efficient Muscle Transduction
    Li, Shaoyong
    Chen, Shuyuan
    Li, Zhongwan
    Zhang, Runyuan
    Lan, Xing
    Jiang, Yuling
    Zheng, Yanyan
    Wan, Changpeng
    Pang, Xiaodong
    Wang, Lijun
    Ye, Guo-Jie
    Wu, Zhenhua
    MOLECULAR THERAPY, 2023, 31 (04) : 410 - 411
  • [2] In Vivo Selection of CNS-Specific Novel AAV Capsid Variants by Directed Evolution
    Wang, Hongxing
    Ng, Robert
    Joo, Kyeil
    Chen, Qingmin
    Huang, Carol
    Carroll, Jenna
    Goulet, Martin
    Sah, Dinah
    Hou, Jay
    MOLECULAR THERAPY, 2018, 26 (05) : 184 - 184
  • [3] Pretreatment with IVIG Reduces Peripheral Transduction of AAV9 Delivered to the CNS
    West, Cara
    Mastis, Bryan
    Vandenberghe, Luk H.
    Richman, Laura K.
    Calcedo, Roberto
    MOLECULAR THERAPY, 2022, 30 (04) : 21 - 21
  • [4] Directed Evolution of AAV1, AAV5 and AAV9 Variants for Efficient Gene Delivery to Eye
    Pendse, Nachiket
    Magdaleno, Eduardo
    Luna, Fabio
    Ge, Tan
    Hintzen, Steph
    Hill, Jake
    Mcelroy, Cameron
    Chen, Jayson
    Tam, Lawrence
    Hudry, Eloise
    Booler, Helen
    Stoner, Kirsten
    Penraat, Kelley
    Hedgeland, Mark
    Babaria, Shraddha
    Walker, John
    Ellis, Scott
    Ozsolak, Fatih
    MOLECULAR THERAPY, 2024, 32 (04) : 479 - 479
  • [5] Identification of New Adeno-Associated Virus 9 (AAV9) Capsid Variants Targeting the BALB/c Mouse Brain through Directed Evolution
    Giannelli, Serena G.
    Luoni, Mirko
    Conti, Eleonora
    Niro, Antonio
    Trepel, Martin
    Koerbelin, Jakob
    Broccoli, Vania
    MOLECULAR THERAPY, 2021, 29 (04) : 149 - 150
  • [6] Deamidation of Adeno-Associated Virus Capsid Impacts Transduction Activity in AAV9
    Meggersee, Rosemary L.
    Sims, Joshua J.
    Lian, Sharon
    Turner, Kevin B.
    Hoff, Henry B.
    Wilson, James M.
    MOLECULAR THERAPY, 2020, 28 (04) : 14 - 14
  • [7] Enhancing AAV9 Transduction and Multi-Capsid Packaging Using Extracellular Vesicles
    Gyorgy, Bence
    Fitzpatrick, Zachary
    Mu, Dakai
    Maguire, Casey A.
    MOLECULAR THERAPY, 2014, 22 : S114 - S114
  • [8] Directed Evolution of the AAV Capsid for Human Embryonic Stem Cell Transduction
    Hirsch, Matthew L.
    Li, Wuping
    Samulski, Richard J.
    MOLECULAR THERAPY, 2009, 17 : S177 - S178
  • [9] Directed evolution of AAV2 yields novel capsid variants
    Maheshri, N
    Kaspar, B
    Schaffer, DV
    MOLECULAR THERAPY, 2004, 9 : S8 - S8
  • [10] Systemic Administration of AAV-PHP.B in Cats Does Not Increase CNS Transduction over AAV9
    Batista, Ana Rita
    Gray-Edwards, Heather
    Reardon, Christopher P.
    Webber, Chelsea J.
    Diffie, Elise
    Maguire, Anne
    Gross, Amanda L.
    Lopez, Kalajan
    Martin, Douglas R.
    Sena-Esteves, Miguel
    MOLECULAR THERAPY, 2018, 26 (05) : 445 - 446
12345